VivoSeq
Other

Myoma

0

Pipeline Programs

1

Active Trials

0

Companies Involved

Myoma is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

5

clinical trials

Completed3 · 60%
Recruiting1 · 20%
Unknown status1 · 20%

Trial Activity

PGL4001 Versus GnRH-agonist in Uterine Myomas
Completed·PPregLem SA·Phase 3·NCT00740831·301 enrolled
PGL4001 Versus Placebo in Uterine Myomas
Completed·PPregLem SA·Phase 3·NCT00755755·241 enrolled
The Value of Myomectomy in Women With Intramural Myoma Before IVF.
Unknown status··N/A·NCT03904368·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)